Align Technology Stock Price, News & Analysis (NASDAQ:ALGN)

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) issued its quarterly earnings data on Wednesday, July, 24th. The medical equipment provider reported $1.26 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.13 by $0.13. The medical equipment provider earned $600.70 million during the quarter, compared to the consensus estimate of $599.86 million. Align Technology had a net margin of 19.06% and a return on equity of 29.26%. The firm's revenue was up 22.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.30 EPS. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for Align Technology.

Align Technology will be holding an earnings conference call on Wednesday, October 23rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Align Technology issued an update on its third quarter earnings guidance on Wednesday, July, 24th. The company provided earnings per share guidance of $1.09-1.16 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.45. The company issued revenue guidance of $585-600 million, compared to the consensus revenue estimate of $623.83 million.

13 equities research analysts have issued 1-year target prices for Align Technology's stock. Their predictions range from $200.00 to $420.00. On average, they expect Align Technology's stock price to reach $272.60 in the next twelve months. This suggests a possible upside of 27.5% from the stock's current price. View Analyst Price Targets for Align Technology.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Align Technology.

News coverage about ALGN stock has trended somewhat positive recently, InfoTrie Sentiment reports. The research firm ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Align Technology earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave media stories about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Align Technology.

Align Technology saw a drop in short interest during the month of September. As of September 30th, there was short interest totalling 3,910,000 shares, a drop of 6.7% from the August 30th total of 4,190,000 shares. Based on an average daily trading volume, of 1,410,000 shares, the short-interest ratio is presently 2.8 days. Currently, 5.4% of the shares of the stock are short sold. View Align Technology's Current Options Chain.

Some companies that are related to Align Technology include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC) and RTI Surgical (RTIX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), Adobe (ADBE), Micron Technology (MU), Paypal (PYPL), Visa (V), salesforce.com (CRM), Mastercard (MA) and Boeing (BA).

Align Technology's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.11%), Stephens Investment Management Group LLC (0.11%), Commerzbank Aktiengesellschaft FI (0.06%), Zurcher Kantonalbank Zurich Cantonalbank (0.05%), Gateway Investment Advisers LLC (0.04%) and Nisa Investment Advisors LLC (0.04%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler and Yuval Shaked. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including Gateway Investment Advisers LLC, Meeder Asset Management Inc., Envestnet Asset Management Inc., Stephens Inc. AR, Nisa Investment Advisors LLC, Pennsylvania Trust Co, Advisor Partners LLC and Wealthfront Advisers LLC. Company insiders that have sold Align Technology company stock in the last year include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Greg J Santora, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Sreelakshmi Kolli, Warren S Thaler and Yuval Shaked. View Insider Buying and Selling for Align Technology.

ALGN stock was purchased by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank , Commerzbank Aktiengesellschaft FI, Heritage Investors Management Corp, Stephens Investment Management Group LLC, Intellectus Partners LLC, Foundations Investment Advisors LLC, Summit Creek Advisors LLC and Pacer Advisors Inc.. Company insiders that have bought Align Technology stock in the last two years include Joseph M Hogan and Vamsi Mohan Raj Pudipeddi. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $213.88.

Align Technology has a market capitalization of $17.08 billion and generates $1.97 billion in revenue each year. The medical equipment provider earns $400.23 million in net income (profit) each year or $4.92 on an earnings per share basis. Align Technology employs 11,660 workers across the globe.View Additional Information About Align Technology.

The official website for Align Technology is http://www.aligntech.com/.

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]